We are live on !
Find out more
Cliff Asness AQR Capital Management
AUM
$287B
Turnover
8.35%
1-Year Est. Return
42.33%
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
This Fund
S&P 500
This Quarter Est. Return
+22.95%
1 Year Est. Return
+42.33%
3 Year Est. Return
+119.89%
5 Year Est. Return
+147.33%
10 Year Est. Return
+543.74%
AUM
$287B
AUM Growth
+$68.5B
(+31%)
Cap. Flow
+$37.5B
Cap. Flow % of AUM
Cap. Flow %
13.08%
Top 10 Holdings %
Top 10 Hldgs %
12.15%
Holding
3,986
New
247
Increased
2,455
Reduced
1,098
Closed
86
Avg Time Held
4.1
years
Top 10 Avg Time Held
3.3
years
Top 20 Avg Time Held
2.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.17B |
| 2 |
Apple
AAPL
|
+$849M |
| 3 |
Chevron
CVX
|
+$746M |
| 4 |
Synopsys
SNPS
|
+$643M |
| 5 |
Wells Fargo
WFC
|
+$633M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$517M |
| 2 |
Booking.com
BKNG
|
+$488M |
| 3 |
Walmart Inc
WMT
|
+$414M |
| 4 |
Sandisk
SNDK
|
+$355M |
| 5 |
Cigna
CI
|
+$325M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.5% |
| 2 | Financials | 14.38% |
| 3 | Industrials | 14.2% |
| 4 | Consumer Discretionary | 10.53% |
| 5 | Healthcare | 10.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3201
Invesco S&P International Developed Momentum ETF
IDMO
$4.24B
| $712K | ﹤0.01% |
11,807
+3,017
| +34% | +$179K |
2025 Q2
4 quarters
|
|
3202
Inspire 100 ETF
BIBL
$512M
| $710K | ﹤0.01% |
12,268
| – | – |
2025 Q1
5 quarters
|
|
3203
LifeVantage
LFVN
$75.3M
| $706K | ﹤0.01% |
113,203
-42,893
| -27% | -$260K |
2025 Q3
3 quarters
|
|
3204
WisdomTree US High Dividend Fund
DHS
$1.64B
| $705K | ﹤0.01% |
6,205
+66
| +1% | +$7.35K |
2025 Q3
3 quarters
|
|
3205
ADC Therapeutics
ADCT
$193M
| $704K | ﹤0.01% |
658,125
+420,488
| +177% | +$1.23M |
2024 Q3
7 quarters
|
|
3206
Petrobras Class A
PBR.A
$124B
| $704K | ﹤0.01% |
48,075
-3,609
| -7% | -$63.6K |
2019 Q1
29 quarters
|
|
3207
iShares iBonds Dec 2029 Term Treasury ETF
IBTJ
$1.53B
| $703K | ﹤0.01% |
32,450
+5,500
| +20% | +$119K |
2025 Q3
3 quarters
|
|
3208
Coca-Cola Femsa
KOF
$24.1B
| $701K | ﹤0.01% |
6,601
+1,850
| +39% | +$194K |
2013 Q2
52 quarters
|
|
3209
Accuray
ARAY
$16.2M
| $701K | ﹤0.01% |
2,719,032
+2,101,555
| +340% | +$782K |
2024 Q4
6 quarters
|
|
3210
FT Vest US Equity Moderate Buffer ETF December
GDEC
$438M
| $701K | ﹤0.01% |
17,600
| – | – |
2025 Q1
5 quarters
|
|
3211
GMO US Value ETF
GMOV
$99.1M
| $700K | ﹤0.01% |
23,509
| – | – |
2026 Q1
1 quarter
|
|
3212
Eaton Vance Tax-Advantaged Dividend Income Fund
EVT
$2.05B
| $700K | ﹤0.01% |
25,274
+2,769
| +12% | +$72.7K |
2025 Q2
4 quarters
|
|
3213
Copel
ELPC
$7.91B
| $697K | ﹤0.01% |
59,820
+13,229
| +28% | +$161K |
2025 Q4
2 quarters
|
|
3214
Eos Energy Enterprises
EOSE
$714M
| $695K | ﹤0.01% |
118,234
-255,015
| -68% | -$1.77M |
2025 Q3
3 quarters
|
|
3215
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.19B
| $695K | ﹤0.01% |
10,339
-4,915
| -32% | -$328K |
2025 Q2
4 quarters
|
|
3216
Vera Therapeutics
VERA
$2.22B
| $694K | ﹤0.01% |
16,173
+165
| +1% | +$6.15K |
2025 Q4
2 quarters
|
|
3217
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$29.7B
| $693K | ﹤0.01% |
6,354
+1,029
| +19% | +$112K |
2026 Q1
1 quarter
|
|
3218
Aeva Technologies
AEVA
$703M
| $690K | ﹤0.01% |
24,039
-9,612
| -29% | -$189K |
2024 Q3
7 quarters
|
|
3219
Brookfield Business Corp Class A Subordinate Voting Shares
BBUC
$5.86B
| $689K | ﹤0.01% |
23,098
-1,770
| -7% | -$58.6K |
2025 Q2
4 quarters
|
|
3220
UFP Technologies
UFPT
$2.26B
| $689K | ﹤0.01% |
2,599
+417
| +19% | +$90.6K |
2022 Q4
14 quarters
|
|
3221
Invesco Dorsey Wright Momentum ETF
PDP
$1.45B
| $688K | ﹤0.01% |
4,537
-85
| -2% | -$11.8K |
2025 Q4
2 quarters
|
|
3222
Limbach Holdings
LMB
$614M
| $688K | ﹤0.01% |
8,929
+49
| +0.6% | +$4.07K |
2023 Q3
11 quarters
|
|
3223
Atlanta Braves Holdings Series A
BATRA
$3.51B
| $687K | ﹤0.01% |
12,202
+1,986
| +19% | +$106K |
2025 Q1
5 quarters
|
|
3224
FT Vest US Equity Buffer ETF June
FJUN
$1.44B
| $686K | ﹤0.01% |
+11,446
| New | +$677K |
2026 Q2
0 quarters
|
|
3225
York Space Systems
YSS
$963M
| $685K | ﹤0.01% |
+27,840
| New | +$864K |
2026 Q2
0 quarters
|
|
Similar funds
Cliff Asness's Q2 2026 Portfolio in Review
As of Q2 2026, Cliff Asness held 3,986 positions worth $287B, up 31% from $218B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Cliff Asness deployed $37.5B of net new capital in Q2 2026, opening 247 new positions and adding to 2,455 existing holdings. Its largest new stake was FedEx Freight: 1,024,555 shares worth $155M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Micron Technology, an estimated $517M trimmed.
- Cliff Asness's largest Q2 2026 buy was FedEx Freight: 1,024,555 shares worth $155M.
- Cliff Asness added most to NVIDIA in Q2 2026, an estimated $1.17B increase.
- Cliff Asness's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $517M.
- Cliff Asness fully exited Masimo in Q2 2026, selling an estimated $147M.
- Cliff Asness's ten largest holdings make up 12% of its $287B portfolio in Q2 2026.
- Cliff Asness opened 247 new positions and closed 86 in Q2 2026.
- Cliff Asness's portfolio value rose 31% quarter-over-quarter to $287B.
Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.